RRC ID 71967
著者 Ogo A, Miyake S, Kubota H, Higashida M, Matsumoto H, Teramoto F, Hirai T, Ueno T.
タイトル The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line.
ジャーナル Anticancer Res
Abstract BACKGROUND/AIM:Eicosapentaenoic acid (EPA) is an unsaturated fatty acid with various bioactivities, including antitumor effects. We previously reported a synergistic antitumor effect of cisplatin (CDDP) and EPA. Here, we examined the underlying mechanism.
MATERIALS AND METHODS:The human oesophageal cancer cell line TE-1 was treated with the combination of EPA and CDDP. Nuclear translocation of NF-κB, a transcription factor involved in cytokine production, was detected by immunohistochemistry. IL-6 levels were measured by ELISA. Apoptosis and cell cycle distribution were evaluated by flow cytometry.
RESULTS:Nuclear translocation of NF-κB in TE-1 cells was synergistically decreased by CDDP and EPA. IL-6 production was increased following treatment with CDDP, but treatment with EPA decreased IL-6 levels. Apoptosis was synergistically induced by CDDP and EPA. A G2/M cell cycle arrest was observed with the combination of CDDP and 150 μM EPA, and S phase arrest with the combination of CDDP and 100 μM EPA.
CONCLUSION:The combination of CDDP and EPA synergistically suppresses NF-κB nuclear translocation and increases apoptosis by inducing cell cycle arrest at the S or G2/M phase.
巻・号 41(4)
ページ 1771-1778
公開日 2021-4-1
DOI 10.21873/anticanres.14942
PII 41/4/1771
PMID 33813381
MeSH Antineoplastic Combined Chemotherapy Protocols / pharmacology* Apoptosis / drug effects Cell Line, Tumor Cisplatin / pharmacology* Drug Synergism Eicosapentaenoic Acid / pharmacology* Esophageal Neoplasms / drug therapy* Esophageal Neoplasms / metabolism Esophageal Neoplasms / pathology G2 Phase Cell Cycle Checkpoints / drug effects Humans Interleukin-6 / metabolism NF-kappa B / metabolism S Phase Cell Cycle Checkpoints / drug effects Signal Transduction
IF 1.994
リソース情報
ヒト・動物細胞 TE-1(RCB1894)